12:00 AM
 | 
Apr 06, 2009
 |  BioCentury  |  Regulation

Long-acting GLP-1 analogs

Long-acting GLP-1 analogs

Company Product Description Status
Novo Nordisk A/S (CSE:NVO; NYSE:NVO) Victoza liraglutide Long-acting GLP-1 analog ...

Read the full 151 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury

Article Purchase

$150 USD
More Info >